Literature DB >> 12127086

Behavioral and neurochemical characterization of alpha(2A)-adrenergic receptor knockout mice.

J Lähdesmäki1, J Sallinen, E MacDonald, B K Kobilka, V Fagerholm, M Scheinin.   

Abstract

Genetic manipulation of mice now provides new tools to evaluate the biological functions of the alpha(2)-adrenergic receptor (alpha(2)-AR) subtypes (alpha(2A), alpha(2B), and alpha(2C)). To investigate the role of the alpha(2A)-AR in the modulation of mouse primary behavioral characteristics and brain neurochemistry, mice with targeted inactivation of the gene for the alpha(2A)-AR were compared with wild-type C57BL/6 control animals. First, a comprehensive behavioral screen was employed to provide a detailed characterization of basic neurologic functions. Thereafter, the mice were analyzed in three models of anxiety, i.e. the elevated-plus maze test, the marble burying test and the open field test. The diurnal activity pattern of the mice was assessed in a 24-h locomotor activity test. Furthermore, receptor autoradiography of the brain was performed using the subtype-non-selective alpha(2)-AR antagonist radioligand [(3)H]RS-79948-197. Lack of the alpha(2A)-AR was associated with alterations in autonomic functions, including increased heart rate and piloerection. The mutant mice also exhibited impaired motor coordination skills, increased anxiety-like behavior and an abnormal diurnal activity pattern. In addition, neurochemical analysis of monoamine neurotransmitters revealed a considerable increase in brain norepinephrine turnover in mice lacking alpha(2A)-AR. Our results provide further support for the crucial role of the alpha(2A)-AR in modulating brain noradrenergic neurotransmission and many aspects of mouse behavior and physiology. Copyright 2002 IBRO

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12127086     DOI: 10.1016/s0306-4522(02)00185-9

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  18 in total

1.  Discrete forebrain neuronal networks supporting noradrenergic regulation of sensorimotor gating.

Authors:  Karen M Alsene; Abha K Rajbhandari; Marcia J Ramaker; Vaishali P Bakshi
Journal:  Neuropsychopharmacology       Date:  2011-01-19       Impact factor: 7.853

Review 2.  A critical inquiry into marble-burying as a preclinical screening paradigm of relevance for anxiety and obsessive-compulsive disorder: Mapping the way forward.

Authors:  Geoffrey de Brouwer; Arina Fick; Brian H Harvey; De Wet Wolmarans
Journal:  Cogn Affect Behav Neurosci       Date:  2019-02       Impact factor: 3.282

Review 3.  Genetic animal models of anxiety.

Authors:  Deborah A Finn; Mark T Rutledge-Gorman; John C Crabbe
Journal:  Neurogenetics       Date:  2003-03-29       Impact factor: 2.660

4.  Ventral striatal noradrenergic mechanisms contribute to sensorimotor gating deficits induced by amphetamine.

Authors:  Karen M Alsene; Katie Fallace; Vaishali P Bakshi
Journal:  Neuropsychopharmacology       Date:  2010-08-04       Impact factor: 7.853

5.  Dorsal BNST α2A-Adrenergic Receptors Produce HCN-Dependent Excitatory Actions That Initiate Anxiogenic Behaviors.

Authors:  Nicholas A Harris; Austin T Isaac; Anne Günther; Kevin Merkel; James Melchior; Michelle Xu; Eghosa Eguakun; Rafael Perez; Brett P Nabit; Stephanie Flavin; Ralf Gilsbach; Brian Shonesy; Lutz Hein; Ted Abel; Arnd Baumann; Robert Matthews; Samuel W Centanni; Danny G Winder
Journal:  J Neurosci       Date:  2018-08-27       Impact factor: 6.167

Review 6.  α2-Adrenoceptors are targets for antipsychotic drugs.

Authors:  Jan Brosda; Florian Jantschak; Heinz H Pertz
Journal:  Psychopharmacology (Berl)       Date:  2014-02-02       Impact factor: 4.530

Review 7.  The age of anxiety: role of animal models of anxiolytic action in drug discovery.

Authors:  John F Cryan; Fabian F Sweeney
Journal:  Br J Pharmacol       Date:  2011-10       Impact factor: 8.739

8.  Dual allosteric modulation of opioid antinociceptive potency by α2A-adrenoceptors.

Authors:  Anne-Julie Chabot-Doré; Magali Millecamps; Lina Naso; Dominic Devost; Phan Trieu; Marjo Piltonen; Luda Diatchenko; Carolyn A Fairbanks; George L Wilcox; Terence E Hébert; Laura S Stone
Journal:  Neuropharmacology       Date:  2015-08-06       Impact factor: 5.250

Review 9.  50 years of hurdles and hope in anxiolytic drug discovery.

Authors:  Guy Griebel; Andrew Holmes
Journal:  Nat Rev Drug Discov       Date:  2013-09       Impact factor: 84.694

10.  Alpha 2A-adrenergic receptor signaling underlies synergistic enhancement of ethanol-induced behavioral impairment by clonidine.

Authors:  Tara Summer Bender; Abdel A Abdel-Rahman
Journal:  Alcohol Clin Exp Res       Date:  2008-12-13       Impact factor: 3.455

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.